SLN peer analysis
Silence Therapeutics (SLN) against its competitors: price, today's move, 1-year return and market value side by side.
SLN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ADRX ADARx Pharmaceuticals | $13.55 | -1.81% | – | – |
| ARCT Arcturus | $9.40 | -0.95% | 24.25% | $293.15M |
| ARWR Arrowhead | $49.02 | -0.45% | 21.94% | $6.82B |
| BNTC Benitec Biopharma | $9.32 | -5.57% | -21.42% | $329.01M |
| IONS Ionis Pharmaceuticals | $28.19 | -9.06% | -59.68% | $4.97B |
| PRQR ProQR Therapeutics | $1.31 | -5.07% | -37.33% | $145.93M |
| RNA Atrium Therapeutics | $8.18 | -2.39% | -88.09% | $142.15M |
| RNAZ TransCode Therapeutics | $1.49 | -1.32% | -85.82% | $25.23M |
| SRPT Sarepta Therapeutics | $16.40 | -4.87% | -0.11% | $1.89B |
| WVE Wave Life Sciences | $3.41 | -2.16% | -56.73% | $672.55M |
| SLN Silence Therapeutics | $19.79 | 0.20% | 205.97% | – |
- SLN's peers: ADRX (ADARx Pharmaceuticals), ARCT (Arcturus), ARWR (Arrowhead), BNTC (Benitec Biopharma), IONS (Ionis Pharmaceuticals), PRQR (ProQR Therapeutics), RNA (Atrium Therapeutics), RNAZ (TransCode Therapeutics).
Updated 2026-11-11 00:48 UTC